We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Ranbaxy Launches Generic Clarithromycin After Defeating Abbott In U.K. Court

Law360 (December 1, 2004, 12:00 AM EST) -- Indian drug maker Ranbaxy Laboratories Ltd. has a launched a generic version of the anti-infective drug clarithromycin in the U.K. after winning a patent infringement lawsuit brought by U.S.-based Abbott Laboratories.

Abbott had taken the Indian generic maker to court seeking to prevent Ranbaxy from launching the drug, but the High Court sided with Ranbaxy.

“In making its ruling in favor of Ranbaxy's arguments that the asserted patent was invalid on various grounds, the court agreed that the specific patent claims asserted by Abbott were invalid...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.